Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Haemonetics's total debt was $1.12B at Sep 26, 2026. For fiscal 2026 it was $1.22B, down 0.0% from the year before. Over ten years it grew 11.6% a year on average. The highest annual figure on record is $1.22B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $1.22B | -0.0% |
| FY2025 | Mar 29, 2025 | $1.22B | +51.6% |
| FY2024 | Mar 30, 2024 | $807.79M | +5.5% |
| FY2023 | Apr 1, 2023 | $765.89M | -1.0% |
| FY2022 | Apr 2, 2022 | $773.59M | +9.3% |
| FY2021 | Apr 3, 2021 | $707.61M | +85.0% |
| FY2020 | Mar 28, 2020 | $382.49M | +9.2% |
| FY2019 | Mar 30, 2019 | $350.12M | +38.0% |
| FY2018 | Mar 31, 2018 | $253.68M | -19.4% |
| FY2017 | Apr 1, 2017 | $314.65M | -22.9% |
| FY2016 | Apr 2, 2016 | $408.00M | -4.6% |
| FY2015 | Mar 28, 2015 | $427.89M | -2.2% |
| FY2014 | Mar 29, 2014 | $437.69M | -9.9% |
| FY2013 | Mar 30, 2013 | $485.69M | +12779.7% |
| FY2012 | Mar 31, 2012 | $3.77M | -22.7% |
| FY2011 | Apr 2, 2011 | $4.88M | -76.2% |
| FY2010 | Apr 3, 2010 | $20.52M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 26, 2026 | $1.12B | -8.2% |
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $1.17B | -4.1% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | $1.22B | -0.0% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $1.22B | -0.0% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $1.22B | -0.0% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $1.22B | +0.1% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $1.22B | +51.6% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $1.22B | +40.7% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $1.22B | +60.7% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $1.22B | +60.0% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $807.79M | +5.5% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $870.59M | +13.5% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $762.23M | -6.8% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $764.95M | -0.7% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $765.89M | -1.0% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $766.78M | -1.3% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $817.75M | +4.7% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $769.99M | -1.8% |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $773.59M | +9.3% |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $777.18M | +150.9% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $780.78M | +68.3% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | $784.37M | +48.5% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | $707.61M | +85.0% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $309.78M | -16.7% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $464.02M | +25.1% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $528.26M | +21.2% |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $382.49M | +9.2% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $371.70M | +8.1% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $370.92M | +7.9% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | $435.69M | +25.2% |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $350.12M | +38.0% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $343.82M | +27.3% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $343.65M | +19.9% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $347.88M | +14.8% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $253.68M | -19.4% |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $270.17M | -19.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $286.60M | – |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $303.04M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | $314.65M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $336.27M | – |
See a number that looks wrong?